HLA (H22): What Really Happened in Today' s Closing Auction?

For fellow retail shareholders, especially those affected by today' s decline, I think it is useful to separate facts from speculation.

HLA closed today, 31 August, at S$2.93, down about 6.1% from Friday' s S$3.12. The Time & Sales data I observed showed approximately 1,337,900 shares matched at S$2.93 during the closing auction &mdash certainly a sizeable transaction deserving attention.

What does it prove?

✅ Significant sell-side/order imbalance &mdash YES
✅ 1.3379m shares matched at S$2.93 &mdash YES
❌ Insider/director dumping &mdash NOT proven
❌ HK/China shareholders dumping &mdash NOT proven

A large institutional or nominee account could potentially be involved, but the Time & Sales data does not identify the ultimate seller. We should therefore avoid jumping to conclusions until SGX disclosures provide further evidence.

One important point when assessing the percentages: HLA completed a S$145m placement of 50m new shares at S$2.90 in May 2026. Therefore, the enlarged share base should be used when calculating the 1.3379m shares as a percentage of HLA.

Today' s fall also does not, by itself, invalidate HLA' s underlying investment thesis. The China Yuchai/genset business and proposed Hong Kong listing remain important potential value-unlocking catalysts.

What I would watch next:

&bull Any director/CEO or substantial-shareholder disclosure
&bull Whether heavy selling continues
&bull Whether S$2.93 holds as support
&bull Trading volume over the next few sessions
&bull Progress of the proposed HK listing
&bull Future earnings and cash flow

My conclusion:
Large auction selling &mdash YES. Seller identified &mdash NO. Insider dumping &mdash NOT established. Worth monitoring closely &mdash DEFINITELY.

I am also affected by today' s decline, so this is an attempt to understand the unusual price action objectively, not investment advice. DYODD.